Buhmann C - Search Results

1

Increased lipid peroxidation in cerebrospinal fluid and plasma from patients with Creutzfeldt-Jakob disease.

Arlt S, Kontush A, Zerr I, Buhmann C, Jacobi C, Schröter A, Poser S, Beisiegel U. Arlt S, et al. Among authors: buhmann c. Neurobiol Dis. 2002 Jul;10(2):150-6. doi: 10.1006/nbdi.2002.0496. Neurobiol Dis. 2002. PMID: 12127153

2

Increased lipoprotein oxidation in Alzheimer's disease.

Schippling S, Kontush A, Arlt S, Buhmann C, Stürenburg HJ, Mann U, Müller-Thomsen T, Beisiegel U. Schippling S, et al. Among authors: buhmann c. Free Radic Biol Med. 2000 Feb 1;28(3):351-60. doi: 10.1016/s0891-5849(99)00247-6. Free Radic Biol Med. 2000. PMID: 10699746

3

Characterization of four lipoprotein classes in human cerebrospinal fluid.

Koch S, Donarski N, Goetze K, Kreckel M, Stuerenburg HJ, Buhmann C, Beisiegel U. Koch S, et al. Among authors: buhmann c. J Lipid Res. 2001 Jul;42(7):1143-51. J Lipid Res. 2001. PMID: 11441143 Free article.

4

CSF-tau, CSF-Abeta1-42, ApoE-genotype and clinical parameters in the diagnosis of Alzheimer's disease: combination of CSF-tau and MMSE yields highest sensitivity and specificity.

Ganzer S, Arlt S, Schoder V, Buhmann C, Mandelkow EM, Finckh U, Beisiegel U, Naber D, Müller-Thomsen T. Ganzer S, et al. Among authors: buhmann c. J Neural Transm (Vienna). 2003 Oct;110(10):1149-60. doi: 10.1007/s00702-003-0017-7. J Neural Transm (Vienna). 2003. PMID: 14523627

5

Plasma and CSF markers of oxidative stress are increased in Parkinson's disease and influenced by antiparkinsonian medication.

Buhmann C, Arlt S, Kontush A, Möller-Bertram T, Sperber S, Oechsner M, Stuerenburg HJ, Beisiegel U. Buhmann C, et al. Neurobiol Dis. 2004 Feb;15(1):160-70. doi: 10.1016/j.nbd.2003.10.003. Neurobiol Dis. 2004. PMID: 14751781

6

Elevated levels of neural recognition molecule L1 in the cerebrospinal fluid of patients with Alzheimer disease and other dementia syndromes.

Strekalova H, Buhmann C, Kleene R, Eggers C, Saffell J, Hemperly J, Weiller C, Müller-Thomsen T, Schachner M. Strekalova H, et al. Among authors: buhmann c. Neurobiol Aging. 2006 Jan;27(1):1-9. doi: 10.1016/j.neurobiolaging.2004.11.013. Neurobiol Aging. 2006. PMID: 16298234 Clinical Trial.

7

Spatio-temporal dynamics of cortical drive to human subthalamic nucleus neurons in Parkinson's disease.

Sharott A, Gulberti A, Hamel W, Köppen JA, Münchau A, Buhmann C, Pötter-Nerger M, Westphal M, Gerloff C, Moll CKE, Engel AK. Sharott A, et al. Among authors: buhmann c. Neurobiol Dis. 2018 Apr;112:49-62. doi: 10.1016/j.nbd.2018.01.001. Epub 2018 Jan 4. Neurobiol Dis. 2018. PMID: 29307661 Free PMC article.

8

Cannabis in Parkinson's Disease: The Patients' View.

Yenilmez F, Fründt O, Hidding U, Buhmann C. Yenilmez F, et al. Among authors: buhmann c. J Parkinsons Dis. 2021;11(1):309-321. doi: 10.3233/JPD-202260. J Parkinsons Dis. 2021. PMID: 33216043

9

Premotor cortical beta synchronization and the network neuromodulation of externally paced finger tapping in Parkinson's disease.

Gulberti A, Schneider TR, Galindo-Leon EE, Heise M, Pino A, Westphal M, Hamel W, Buhmann C, Zittel S, Gerloff C, Pötter-Nerger M, Engel AK, Moll CKE. Gulberti A, et al. Among authors: buhmann c. Neurobiol Dis. 2024 Jul;197:106529. doi: 10.1016/j.nbd.2024.106529. Epub 2024 May 11. Neurobiol Dis. 2024. PMID: 38740349 Free article.

10

Plasma concentrations of 5-HT, 5-HIAA, norepinephrine, epinephrine and dopamine in ecstasy users.

Stuerenburg HJ, Petersen K, Bäumer T, Rosenkranz M, Buhmann C, Thomasius R. Stuerenburg HJ, et al. Among authors: buhmann c. Neuro Endocrinol Lett. 2002 Jun;23(3):259-61. Neuro Endocrinol Lett. 2002. PMID: 12080289

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

174 results

Search Page

Filters